Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Amarantus Bioscience Holdings Inc

+ Add to Watchlist

AMBS:US

0.0595 USD 0.0085 16.67%

As of 20:10:04 ET on 03/26/2015.

Company Profile for Amarantus Bioscience Holdings Inc (AMBS)

Amarantus Bioscience Holdings, Inc. is a biotechnology holding company. The Company, through its subsidiaries, certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, traumatic brain Injury, Ischemic heart disease and other human diseases.

Contact Information

Amarantus Bioscience Holdings Inc

675 Almanor Avenue
Sunnyvale, CA 94085
United States
Phone: 1-408-737-2734

Key Executives for Amarantus Bioscience Holdings Inc (AMBS)

Gerald E CommissiongPresident/CEO/COORobert FarrellChief Financial Officer
John W CommissiongChief Scientific Ofcr/Co-FounderElise BrownellSenior VP:Ops & Project Mgmt
Marc E FaerberVP:Financial Ops/TreasurerAimee BoutcherInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil